Prevention and treatment of exit-site and tunnel infections in pediatric continuous peritoneal dialysis

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Sojo, Ernesto T ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

Author keywords

Pediatric exit site infections; Pediatric patients; Pediatric peritoneal access

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE GLUCONATE; CLOXACILLIN; COTRIMOXAZOLE; PENICILLIN G; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; SODIUM CHLORIDE;

BACTERIAL COLONIZATION; CATHETER INFECTION; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INFECTION RISK; KIDNEY FAILURE; PERITONEAL CATHETER; PERITONITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; CHILD; HUMANS; NASAL CAVITY; PERITONEAL DIALYSIS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0033394639     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Twardowski Z, Khanna R. Peritoneal dialysis access and exit-site care. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1994: 271-314.
2. Rinaldi S, Sera F, Verrina E, Edefonti A, Perfumo F, Sorino P. The Italian Registry of Pediatric Chronic Peritoneal Dialysis: A ten years experience with chronic peritoneal dialysis catheters. Perit Dial Int. 1998; 18:71-4.
3. Lewis M, Smith T, Postlethwaite R, Welb N. A comparison of double cuffed with single cuffed Tenckhoff catheters in the prevention of infection in pediatric patients. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1997; 13:274-6.
4. Furth SL. The problem of exit site infections in pediatric PD patients. A North American Pediatric Renal Transplant Cooperative Study report. In: University of Missouri, Columbia, ed. Proceedings of the 9th Annual Pediatric Peritoneal Dialysis Symposium at the 18th Annual Conference on Peritoneal Dialysis Symposium at the 18th Annual Conference on Peritoneal Dialysis; 23-25 February 1998; Nashville, Tennessee, U.S.A.
5. Sojo E, Bisigniano L, Grosman M, Bailez M. Ten years experience with CAPD catheters. In: Fine RN, Warady BA, Alexander ST, eds. CAPD/CCPD in Children. 2nd ed. Dordrecht: Kluwer Academic Publishers; 1998: 263-80.
6. Kuizon B, Melocoton TL, Holloway M, Ingles S, Hejing S, Fonkalsrud EW, et al. Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution. Pediatr Nephrol. 1995; 9(Suppl):S12-17.
7. Honda M, Litaka K, Kawaguchi H, Hoshi S, Akashi S, Kohsaa T, et al. The Japanese National Registry Data in pediatric CAPD patients: A report of the study group of the pediatric conference. Perit Dial Int. 1996; 16:269-75.
8. Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A. Renal transplantation, chronic dialysis and chronic renal insufficiency in children and adolescents: The 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephol. 1997; 11:49-64.
9. Jones L, Tweedy L, Warady B. The impact of exit site care and catheter design on the incidence of catheter related infections. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:302-5.
10. Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient database: A report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int. 1996; 49(Suppl 53):S68-71.
11. Penaloza J, Turconi A, Delgado N, Fernandez G, Sojo E. Incidence of PD associated peritonitis and exit site infections in children converted to Y set disconnect system [Abstract]. Pediatr Nephrol. 1995; 9(6):C95.
12. Warchols S, Roszkowska BM, Sieniawska M. Swan neck peritoneal dialysis catheter: Five years experience in children. Perit Dial Int. 1998; 18:183-7.
13. Gokal R, Alexander S, Ash S, Chen TW, Danielson A, Holmes C, et al. Peritoneal catheters and exit site practices toward optimum peritoneal access: 1998 update. Perit Dial Int. 1998; 18:11-33.
14. Tranæus A. Peritonitis in pediatrics continuous peritoneal dialysis. In: Fine RN, Warady BA, Alexander ST, eds. CAPD/CCPD in Children. 2nd ed. Dordrecht: Kluwer Academic Publishers; 1998:301-47.
15. Pecoits-Filko RFS, Twardowski ZJ, Khanna R, Kim YL, Goel S, Moore H. The effect of antibiotic prophylaxis on the healing of exit-sites of PD catheters in rats. Perit Dial Int. 1998; 18:60-3.
16. Grosman M, Hernandez G, Maldonado S, Bisigniano L, Sojo E. Iodine povidone (10%) soap solution or hypertonic saline (3% NaCl): Which is the best for the prevention of ESI/TI in children on CAPD? A prospective randomized study [Abstract]. Rev Nefrol Dial Transplant (B Aires). 1998; 46(Suppl):65.
17. Kingwatanakul P, Warady B. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1997; 13:281-4.
18. Pérez-Fontán M, García-Falcón T, Rosales M, Rodrigues-Carmona A, Adeva M, Rodiguez-Lozana I, et al. Treatment of Staph aureus nasal carriages in CAPD with mupirocin: Long term results. Am J Kidney Dis. 1993; 22:708-12.
19. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett S, O'Brien M, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis. 1991; 18:225-31.
20. Hanevold CD, Fisher MC, Waltz R, Bartosh S, Baluarte HJ. Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis. Pedriatr Nephrol. 1995; 9:609-11.
21. Mupirocin Study Group. Nasal mupirocin prevents Staph aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol. 1996; 7:2403-8.
22. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis. 1996; 27:695-700.
23. Blowey DC, Warady BA, McFarland KS. The treatment of Staph aureus nasal carriage in pediatric peritoneal dialysis patients. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10:297-9.
24. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Peritoneal dialysis related peritonitis treatment recommendations: 1996 update. Perit Dial Int. 1996; 16:557-73.
25. Schroeder CH, Severynen R, de Jong M, Monnem L. Chronic tunnel infection in children: Removal and replacement of CAPD catheter in a single operation. Perit Dial Int. 1993; 13:198-200.
26. Prowant BF, Warady BA, Nolph KD. Peritoneal dialysis catheter exit-site care: Results of an international study. Perit Dial Int. 1993; 13:149-54.
27. Neu AM, Kohaut EC, Warady BA. Current approach to peritoneal access in North American children: A report of the Pediatric Peritoneal Dialysis Study Consortium. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:289-92.